Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vik Meadows

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Hepatology (Baltimore, Md.)|July 2, 2025
Retraction: Blocking H1/H2 histamine receptors inhibits damage/fibrosis in Mdr2 -/- mice and human cholangiocarcinoma tumorigenesisLindsey Kennedy, Laura Hargrove, Jennifer Demieville, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|September 16, 2019
Downregulation of hepatic stem cell factor by Vivo-Morpholino treatment inhibits mast cell migration and decreases biliary damage/senescence and liver fibrosis in Mdr2<sup>-/-</sup> miceVik Meadows, Lindsey Kennedy, Laura Hargrove, et al.
Hepatology (Baltimore, Md.)|March 31, 2018
Blocking H1/H2 histamine receptors inhibits damage/fibrosis in Mdr2<sup>-/-</sup> mice and human cholangiocarcinoma tumorigenesisLindsey Kennedy, Laura Hargrove, Jennifer Demieville, et al.
Hepatology Communications|July 8, 2022
Mast cells selectively target large cholangiocytes during biliary injury via H2HR-mediated cAMP/pERK1/2 signalingTianhao Zhou, Vik Meadows, Debjyoti Kundu, et al.
JCI Insight|February 24, 2026
Single-cell Spatial Transcriptomics Reveals Hepatocyte Reprogramming in Fontan Associated Liver DiseaseBrandon M Lehrich, Jordann N Lewis, Vik Meadows, et al.
Hepatology (Baltimore, Md.)|April 30, 2021
Inhibition of Secretin/Secretin Receptor Axis Ameliorates NAFLD PhenotypesLixian Chen, Nan Wu, Lindsey Kennedy, et al.
The Journal of Biological Chemistry|August 1, 2024
The arginine and nitric oxide metabolic pathway regulate the gut colonization and expansion of Ruminococcous gnavusJuan A Flores, Jayson M Antonio, Panan Suntornsaratoon, et al.
Cancers|March 25, 2022
Molecular Mechanisms Linking Risk Factors to Cholangiocarcinoma DevelopmentLudovica Ceci, Tianhao Zhou, Ilaria Lenci, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|March 25, 2024
Characterization of individual bile acids in vivo utilizing a novel low bile acid mouse modelRulaiha Taylor, Zhenning Yang, Zakiyah Henry, et al.
Hepatology (Baltimore, Md.)|February 17, 2023
p16 INK4A drives nonalcoholic fatty liver disease phenotypes in high fat diet fed mice through biliary E2F1/FOXO1/IGF-1 signalingDebjyoti Kundu, Lindsey Kennedy, Tianhao Zhou, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Hepatology (Baltimore, Md.)|July 2, 2025
Retraction: Blocking H1/H2 histamine receptors inhibits damage/fibrosis in Mdr2 -/- mice and human cholangiocarcinoma tumorigenesisLindsey Kennedy, Laura Hargrove, Jennifer Demieville, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|September 16, 2019
Downregulation of hepatic stem cell factor by Vivo-Morpholino treatment inhibits mast cell migration and decreases biliary damage/senescence and liver fibrosis in Mdr2<sup>-/-</sup> miceVik Meadows, Lindsey Kennedy, Laura Hargrove, et al.
Hepatology (Baltimore, Md.)|March 31, 2018
Blocking H1/H2 histamine receptors inhibits damage/fibrosis in Mdr2<sup>-/-</sup> mice and human cholangiocarcinoma tumorigenesisLindsey Kennedy, Laura Hargrove, Jennifer Demieville, et al.
Hepatology Communications|July 8, 2022
Mast cells selectively target large cholangiocytes during biliary injury via H2HR-mediated cAMP/pERK1/2 signalingTianhao Zhou, Vik Meadows, Debjyoti Kundu, et al.
JCI Insight|February 24, 2026
Single-cell Spatial Transcriptomics Reveals Hepatocyte Reprogramming in Fontan Associated Liver DiseaseBrandon M Lehrich, Jordann N Lewis, Vik Meadows, et al.
Hepatology (Baltimore, Md.)|April 30, 2021
Inhibition of Secretin/Secretin Receptor Axis Ameliorates NAFLD PhenotypesLixian Chen, Nan Wu, Lindsey Kennedy, et al.
The Journal of Biological Chemistry|August 1, 2024
The arginine and nitric oxide metabolic pathway regulate the gut colonization and expansion of Ruminococcous gnavusJuan A Flores, Jayson M Antonio, Panan Suntornsaratoon, et al.
Cancers|March 25, 2022
Molecular Mechanisms Linking Risk Factors to Cholangiocarcinoma DevelopmentLudovica Ceci, Tianhao Zhou, Ilaria Lenci, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|March 25, 2024
Characterization of individual bile acids in vivo utilizing a novel low bile acid mouse modelRulaiha Taylor, Zhenning Yang, Zakiyah Henry, et al.
Hepatology (Baltimore, Md.)|February 17, 2023
p16 INK4A drives nonalcoholic fatty liver disease phenotypes in high fat diet fed mice through biliary E2F1/FOXO1/IGF-1 signalingDebjyoti Kundu, Lindsey Kennedy, Tianhao Zhou, et al.
Pageof 5